|
1
|
Nordberg M and Nordberg GF: Trace element
research-historical and future aspects. J Trace Elem Med Biol.
38:46–52. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kozeniecki M, Ludke R, Kerner J and
Patterson B: Micronutrients in liver disease: Roles, risk factors
for deficiency and recommendation for supplementation. Nutr Clin
Pract. 35:50–62. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Himoto T and Masaki T: Current trends of
essential trace elements in patients with chronic liver diseases.
Nutrients. 12(2084)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Khan RS, Bril F, Cusi K and Newsome PN:
Modulation of insulin resistance in nonalcoholic fatty liver
disease. Hepatology. 70:711–724. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dubey P, Thakur V and Chattopadhyay M:
Role of minerals and trace elements in diabetes and insulin
resistance. Nutrients. 12(1864)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Moriyama M, Matsumura H, Fukushima A,
Ohkido K and Arakawa Y, Nirei K, Yamagami H, Kaneko M, Tanaka N and
Arakawa Y: Clinical significance of evaluation of serum zinc
concentrations in C-viral chronic liver disease. Dig Dis Sci.
51:1967–1977. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Himoto T, Hosomi N, Nakai S, Deguchi A,
Kinekawa F, Matsuki M, Yachida M, Masaki T, Kurokochi K, Watanabe
S, et al: Efficacy of zinc administration in patients with
hepatitis C virus-related chronic liver disease. Scand J
Gastroenterol. 42:1078–1087. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Himoto T, Yoneyama H, Kurokohchi K, Inukai
M, Masugata H, Goda F, Haba R, Watanabe S, Kubota S, Senda S and
Masaki T: Selenium deficiency is associated with insulin resistance
in patients with hepatitis C virus-related chronic liver disease.
Nutr Res. 31:829–835. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Himoto T, Nomura T, Tani J, Miyoshi H,
Morishita A, Yoneyama H, Haba R, Masugata H and Masaki T:
Exacerbation of insulin resistance and hepatic steatosis deriving
from zinc deficiency in patients with HCV-related chronic liver
disease. Biol Trace Elem Res. 163:81–88. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ito T, Ishigami M, Ishizu Y, Kuzuya T,
Honda T, Ishikawa T, Toyoda H, Kumada T and Fujishiro M:
Correlation of serum zinc levels with pathological and laboratory
findings in patients with nonalcoholic fatty liver disease. Eur J
Gastroenterol Hepatol. 32:748–753. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Reja M, Makar M, Visaria A, Marino D and
Rustgi V: Increased serum selenium levels are associated with
reduced risk of advanced liver fibrosis and all-cause mortality in
NAFLD patients: National Health and Nutrition Examination Survey
(NHANES) III. Ann Hepatol. 19:635–640. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Buzzetti E, Petta S, Manuguerra R, Luong
TV, Cabibi D, Corradini E, Craxi A, Pinzani M, Tsochatzis E and
Pietrangelo A: Evaluating the association of serum ferritin and
hepatic iron with disease severity in non-alcoholic fatty liver
disease. Liver Int. 39:1325–1334. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Aigner E, Strasser M, Haufe H, Sonnweber
T, Hohia F, Stadimayr A, Solioz M, Tilg H, Patsch W, Weiss G, et
al: A role for low hepatic copper concentrations in nonalcoholic
fatty liver disease. Am J Gastroenterol. 105:1978–1985.
2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nobili V, Siotto M, Bedogni G, Rava L,
Pietrobattista A, Panera N, Alisi A and Squitti R: Levels of serum
seruloplasmin associated with pediatric nonalcoholic fatty liver
disease. J Pediatr Gastroenterol Nutr. 56:370–375. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
García-Monzón C, Lo lacono O, Mayoral R,
González-Rodrínguez A, Miqulena-Colina ME, Lozano-Rodríguez T,
García-Pozo L, Vargas-Castrillón J, Casado M, Boscá L, et al:
Hepatic insulin resistance is associated with increased apoptosis
and fibrogenesis in nonalcoholic steatohepatitis and chronic
hepatitis C. J Hepatol. 54:142–152. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Milic S, Mikolasevic I, Orlic L, Devcic E,
Starcevic-Cizmarevic N, Stimac D, Kapovic M and Ristic S: The role
of iron and iron overload in chronic liver disease. Med Sci Monit.
22:2144–2151. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Matteoni CA, Younossi ZM, Gramlich T,
Boparai N, Liu YC and McCullough AJ: Nonalcoholic fatty liver
disease: A spectrum of clinical and pathological severity.
Gastroenterology. 116:1413–1419. 1999.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sandres-Sauné K, Abravanel F, Nicot F,
Peron JM, Alric L, Boineau J, Pasquier C and Izopet J: Detection
and quantitationof HCV RNA using real-time PCV after automated
sample processing. J Med Virol. 79:1821–1826. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sunderman FW Jr: Atomic absorption
spectrometry of trace metals in clinical pathology. Hum Pathol.
4:549–582. 1973.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kodama H, Tanaka M, Naito Y, Katayama K
and Moriyama M: Japan's practical guidelines for zinc deficiency
with a particular focus on taste disorders, inflammatory bowel
disease, and liver cirrhosis. Int J Mol Sci.
21(2941)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kodama H, Asagiri K, Ida S, Etani Y,
Koyama H, Soh H, Tanaka Y, Takayanagi M, Funakoshi M and Yoshida M:
Diagnosis and treatment of selenium deficiency. J Jpn Sci Clin
Nutr. 40:239–283. 2015.
|
|
22
|
Mehta KJ, Farnaud SJ and Sharp PA: Iron
and liver fibrosis: Mechanistic and clinical aspects World J.
Gastroenterol. 25:521–538. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cardiff RD, Miller CH and Munn RJ: Manual
hematoxylin and eosin staining of mouse tissue sections. Cold
Spring Harb Protc. 2014:655–658. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ichida F, Tsuji T, Omata M, Ichida T,
Inoue K, Kamimura T, Yamada G, Hino K, Yokosuka O and Suzuki H: New
Inuyama classification: New criteria for histological assessment of
chronic hepatitis. Int Hepatol Commun. 6:112–119. 1996.
|
|
25
|
Brunt EM, Janey CG, Di Bisceglie AM,
Neuschwander-Tetri BA and Bacon BR: Nonalcoholic steatohepatitis: A
proposal for grading and staging the histological lesions. Am J
Gastroenterol. 94:2467–2474. 1999.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kohgo Y, Ikuta K, Ohtake T, Torimoto Y and
Kato J: Iron overload and cofactors with special reference to
alcohol, hepatitis C virus infection and steatosis/insulin
resistance. World J Gastroenterol. 13:4699–4706. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Valenti L, Fracanzari AL, Dongiovanni P,
Rovida S, Rametta R, Fatta E, Pulixi EA, Maggioni M and Fargion S:
A randomized trial of iron depletion in patients with nonalcoholic
fatty liver disease and hyperferritinemia. World J Gastroenterol.
20:3002–3010. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Himoto T and Masaki T: Associations
between zinc deficiency and metabolic abnormalities in patients
with chronic liver disease. Nutrients. 10(88)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Burk RF, Early DS, Hill KE, Palmer IS and
Boeglin ME: Plasma selenium in patients with cirrhosis. Hepatology.
27:794–798. 1998.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Frenández-Real JM, López-Bermejo A and
Ricart W: Cross-talk between iron metabolism and diabetes.
Diabetes. 51:2348–2354. 2002.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fernandez M, Lokan J, Leung C and Grigg A:
A critical evaluation of the roles of iron overload in fatty liver
disease. J Gastroenterol Hepatol. 37:1873–1883. 2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
McNall AD, Etherton TD and Fosmire GJ: The
impaired growth induced by zinc deficiency in rats is associated
with decreased expression of hepatic insulin-like growth factor I
and growth hormone receptor genes. J Nutr. 125:874–879.
1995.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Himoto T, Tani J, Miyoshi H, Yoneyama H,
Mori H, Inukai M, Masugata H, Goda F, Senda S, Haba R and Masaki T:
The ratio of insulin-like growth factor/insulin-like growth
factor-binding protein-3 in sera of patients with hepatitis C
virus-related chronic liver disease as a predictive marker of
insulin resistance. Nutr Res. 33:27–33. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yao Y, Miao X, Zhu D, Li D, Zhang Y, Song
C and Liu K: Insulin-like growth factor-1 and non-alcoholic fatty
liver disease: A systemic review and-meta-analysis. Endocrine.
65:227–237. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Steinbrenner H: Interference of selenium
and selenoproteins with insulin-regulated carbohydrate and lipid
metabolism. Free Radic Biol Med. 65:1538–1547. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang XL, Yang TB, Wei J, Lei GH and Zeng
C: Association between serum selenium level and type 2 diabetes
mellitus: A non-linear dose-response meta-analysis of observational
studies. Nutr J. 15(48)2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Polyzos SA, Kountouras J, Goulas A and
Duntas L: Selenium and selenoprotein P in nonalcoholic fatty liver
disease. Hormone (Athens). 19:61–72. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cetindagli I, Kara M, Tanoglu A, Ozalper
V, Aribal S, Hancerli Y, Unal M, Ozarı O, Hira S, Kaplan M and
Yazgan Y: Evaluation of endothelial dysfunction in patients with
nonalcoholic fatty liver disease: Association of selenoprotein P
with carotid intima-media thickness and endothelium-dependent
vasodilation. Clin Res Hepatol Gastroenterol. 41:516–524.
2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Polyzos SA, Kountouras J, Mavrouli M,
Katsinelos P, Doulberis M, Gavana E and Duntas L: Selenoprotein P
in patients with nonalcoholic fatty liver disease. Exp Clin
Endocrinol Diabetes. 127:598–602. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Bao B, Prasad AS, Beck FW, Fitzgerald JT,
Snell D, Bao GW, Singh T and Cardozo LJ: Zinc decreases C-reactive
protein, lipid peroxidation, and inflammatory cytokines in elderly
subjects: A potential implication of zinc as an atheroprotective
agent. Am J Clin Nutr. 91:1634–1641. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Fathi M, Alavinejad P, Haidari Z and Amani
R: The effect of zinc supplementation on steatosis severity and
liver function enzymes in overweight/obese patients with mild to
moderate non-alcoholic fatty liver following calorie-restricted
diet: A double-blind, randomized placebo-controlled trial. Biol
Trace Elem Res. 197:394–404. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Spaur M, Nigra AE, Sanchez TR, Navas-Acien
A, Lazo M and Wu HC: Association of blood manganese, selenium with
steatosis, fibrosis in the National Health and Nutrition
Examination Survey, 2017-2018. Environ Res.
213(113647)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Wang C, Yang S, Zhang N, Mu Y, Ren H, Wang
Y and Li K: Long-term supranutritional supplementation with
selenate decreases hyperglycemia and promotes fatty liver
degeneration by inducing hyperinsulinemia in diabetic db/db mice.
PLoS One. 9(e101315)2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Bonnefont-Rousselot D, Ratziu V, Giral P,
Charlotte F, Beuclear I and Poynard T: Lido Study Group. Blood
oxidative stress markers are unreliable markers of hepatic
steatosis. Aliment Pharmacol Ther. 23:91–98. 2006.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Miyata M, Matsushita K, Shindo R,
Shimokawa Y, Sugiura Y and Yamashita M: Selenoneine ameliorates
hepatocellular injury and hepatic steatosis in a mouse model of
NAFLD. Nutrients. 12(1898)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Consolo M, Amoroso A, Spandidos DA and
Mazzarino MC: Matrix metalloproteinases and their inhibitors as
markers of inflammation and fibrosis in chronic liver disease
(Review). Int J Mol Med. 24:143–152. 2009.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ding M, Potter JJ, Liu X, Torbenson MS and
Mezey E: Selenium supplementation decreases hepatic fibrosis in
mice after chronic carbon tetrachloride administration. Biol Trace
Elem Res. 133:83–97. 2010.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Arain SA, Kazi TG, Afridi HI, Talpur FN,
Mughal MA, Shah F, Arian SS and Panhwar AH: Estimation of copper
and iron burden in biological samples of various stages of
hepatitis C and liver cirrhosis patients. Biol Trace Elem Res.
160:197–205. 2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chen C, Zhou Q, Yang R, Wu Z, Yuan H,
Zhang N, Zhi M, Zhang Y, Ni X, Wang Z, et al: Copper exposure
association with prevalence of non-alcoholic fatty liver disease
and insulin resistance among US adults (NHANES 2011-2014).
Ecotoxicol Environ Saf. 218(112295)2021.PubMed/NCBI View Article : Google Scholar
|
